Cellular FLICE-like inhibitory proteins (c-FLIPs): Fine-tuners of life and death decisions

Experimental Cell Research

Volumn 318, Issue 11, 2012, Pages 1324-1331

  Öztürk, Selcen ^a   Schleich, Kolja ^a,b   Lavrik, Inna N ^a,b,c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Apoptosis; C FLIP; Caspase 8; Death receptor; DISC

Indexed keywords

DEATH RECEPTOR; FLICE INHIBITORY PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

APOPTOSIS; CANCER CELL; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MODIFICATION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84861673635     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2012.01.019     Document Type: Review

References (57)

1. Krammer P.H. CD95's deadly mission in the immune system. Nature 2000, 407:789-795.
2. Krammer P.H., Arnold R., Lavrik I.N. Life and death in peripheral T cells. Nat. Rev. Immunol. 2007, 7:532-542.
3. Lavrik I., Golks A., Krammer P.H. Death receptor signaling. J. Cell Sci. 2005, 118:265-267.
4. Trauth B.C., Klas C., Peters A.M., Matzku S., Moller P., Falk W., Debatin K.M., Krammer P.H. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 1989, 245:301-305.
5. Suda T., Takahashi T., Golstein P., Nagata S. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 1993, 75:1169-1178.
6. Martinou J.C., Green D.R. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2001, 2:63-67.
7. Liston P., Roy N., Tamai K., Lefebvre C., Baird S., Cherton-Horvat G., Farahani R., McLean M., Ikeda J.E., MacKenzie A., Korneluk R.G. Suppression of apoptosis in mammalian cells by NAIP and a related family of IAP genes. Nature 1996, 379:349-353.
8. Kataoka T., Budd R.C., Holler N., Thome M., Martinon F., Irmler M., Burns K., Hahne M., Kennedy N., Kovacsovics M., Tschopp J. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr. Biol. 2000, 10:640-648.
9. Kreuz S., Siegmund D., Rumpf J.J., Samel D., Leverkus M., Janssen O., Hacker G., Dittrich-Breiholz O., Kracht M., Scheurich P., Wajant H. NF kappa B activation by Fas is mediated through FADD, caspase-8, and RIP and is inhibited by FLIP. J. Cell Biol. 2004, 166:369-380.
10. Desbarats J., Birge R.B., Mimouni-Rongy M., Weinstein D.E., Palerme J.S., Newell M.K. Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat. Cell Biol. 2003, 5:118-125.
11. Neumann L., Pforr C., Beaudouin J., Pappa A., Fricker N., Krammer P.H., Lavrik I.N., Eils R. Dynamics within the CD95 death-inducing signaling complex decide life and death of cells. Mol. Syst. Biol. 2010, 6:352.
12. Schneider P., Thome M., Burns K., Bodmer J.L., Hofmann K., Kataoka T., Holler N., Tschopp J. TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. Immunity 1997, 7:831-836.
13. Thome M., Schneider P., Hofmann K., Fickenscher H., Meinl E., Neipel F., Mattmann C., Burns K., Bodmer J.L., Schroter M., Scaffidi C., Krammer P.H., Peter M.E., Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997, 386:517-521.
14. Bertin J., Armstrong R.C., Ottilie S., Martin D.A., Wang Y., Banks S., Wang G.H., Senkevich T.G., Alnemri E.S., Moss B., Lenardo M.J., Tomaselli K.J., Cohen J.I. Death effector domain-containing herpesvirus and poxvirus proteins inhibit both Fas- and TNFR1-induced apoptosis. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:1172-1176.
15. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L.E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature 1997, 388:190-195.
16. Golks A., Brenner D., Fritsch C., Krammer P.H., Lavrik I.N. c-FLIPR, a new regulator of death receptor-induced apoptosis. J. Biol. Chem. 2005, 280:14507-14513.
17. Scaffidi C., Schmitz I., Krammer P.H., Peter M.E. The role of c-FLIP in modulation of CD95-induced apoptosis. J. Biol. Chem. 1999, 274:1541-1548.
18. Krueger A., Schmitz I., Baumann S., Krammer P.H., Kirchhoff S. Cellular flice-inhibitory protein splice variants inhibit different steps of caspase-8 activation at the CD95 death-inducing signaling complex. J. Biol. Chem. 2001, 276:20633-20640.
19. Guiet C., Silvestri E., De Smaele E., Franzoso G., Vito P. c-FLIP efficiently rescues TRAF-2-/- cells from TNF-induced apoptosis. Cell Death Differ. 2002, 9:138-144.
20. Golks A., Brenner D., Krammer P.H., Lavrik I.N. The c-FLIP-NH2 terminus (p22-FLIP) induces NF-kappa B activation. J. Exp. Med. 2006, 203:1295-1305.
21. Djerbi M., Darreh-Shori T., Zhivotovsky B., Grandien A. Characterization of the human FLICE-inhibitory protein locus and comparison of the anti-apoptotic activity of four different flip isoforms. Scand. J. Immunol. 2001, 54:180-189.
22. Ueffing N., Keil E., Freund C., Kuhne R., Schulze-Osthoff K., Schmitz I. Mutational analyses of c-FLIPR, the only murine short FLIP isoform, reveal requirements for DISC recruitment. Cell Death Differ. 2008, 15:773-782.
23. Micheau O. Cellular FLICE-inhibitory protein: an attractive therapeutic target?. Expert Opin. Ther. Targets 2003, 7:559-573.
24. Poukkula M., Kaunisto A., Hietakangas V., Denessiouk K., Katajamaki T., Johnson M.S., Sistonen L., Eriksson J.E. Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail. J. Biol. Chem. 2005, 280:27345-27355.
25. S. Shirley, O. Micheau, Targeting c-FLIP in cancer, Cancer Lett. (in press).
26. Micheau O., Lens S., Gaide O., Alevizopoulos K., Tschopp J. NF-kappaB signals induce the expression of c-FLIP. Mol. Cell. Biol. 2001, 21:5299-5305.
27. Kreuz S., Siegmund D., Scheurich P., Wajant H. NF-kappaB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol. Cell. Biol. 2001, 21:3964-3973.
28. Kim Y., Suh N., Sporn M., Reed J.C. An inducible pathway for degradation of FLIP protein sensitizes tumor cells to TRAIL-induced apoptosis. J. Biol. Chem. 2002, 277:22320-22329.
29. Chang L., Kamata H., Solinas G., Luo J.L., Maeda S., Venuprasad K., Liu Y.C., Karin M. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell 2006, 124:601-613.
30. Schmitz I., Weyd H., Krueger A., Baumann S., Fas S.C., Krammer P.H., Kirchhoff S. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort. J. Immunol. 2004, 172:2194-2200.
31. Kaunisto A., Kochin V., Asaoka T., Mikhailov A., Poukkula M., Meinander A., Eriksson J.E. PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability. Cell Death Differ. 2009, 16:1215-1226.
32. Yang B.F., Xiao C., Roa W.H., Krammer P.H., Hao C. Calcium/calmodulin-dependent protein kinase II regulation of c-FLIP expression and phosphorylation in modulation of Fas-mediated signaling in malignant glioma cells. J. Biol. Chem. 2003, 278:7043-7050.
33. Kundu M., Pathak S.K., Kumawat K., Basu S., Chatterjee G., Pathak S., Noguchi T., Takeda K., Ichijo H., Thien C.B., Langdon W.Y., Basu J. A TNF- and c-Cbl-dependent FLIP(S)-degradation pathway and its function in Mycobacterium tuberculosis-induced macrophage apoptosis. Nat. Immunol. 2009, 10:918-926.
34. Geserick P., Drewniok C., Hupe M., Haas T.L., Diessenbacher P., Sprick M.R., Schon M.P., Henkler F., Gollnick H., Walczak H., Leverkus M. Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis. Oncogene 2008, 27:3211-3220.
35. Chang D.W., Xing Z., Pan Y., Algeciras-Schimnich A., Barnhart B.C., Yaish-Ohad S., Peter M.E., Yang X. c-FLIP(L) is a dual function regulator for caspase-8 activation and CD95-mediated apoptosis. EMBO J. 2002, 21:3704-3714.
36. Micheau O., Thome M., Schneider P., Holler N., Tschopp J., Nicholson D.W., Briand C., Grutter M.G. The long form of FLIP is an activator of caspase-8 at the Fas death-inducing signaling complex. J. Biol. Chem. 2002, 277:45162-45171.
37. Yeh W.C., Itie A., Elia A.J., Ng M., Shu H.B., Wakeham A., Mirtsos C., Suzuki N., Bonnard M., Goeddel D.V., Mak T.W. Requirement for Casper (c-FLIP) in regulation of death receptor-induced apoptosis and embryonic development. Immunity 2000, 12:633-642.
38. Sharp D.A., Lawrence D.A., Ashkenazi A. Selective knockdown of the long variant of cellular FLICE inhibitory protein augments death receptor-mediated caspase-8 activation and apoptosis. J. Biol. Chem. 2005, 280:19401-19409.
39. Fricker N., Beaudouin J., Richter P., Eils R., Krammer P.H., Lavrik I.N. Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL. J. Cell Biol. 2010, 190:377-389.
40. Hu W.H., Johnson H., Shu H.B. Activation of NF-kappaB by FADD, Casper, and caspase-8. J. Biol. Chem. 2000, 275:10838-10844.
41. Dohrman A., Kataoka T., Cuenin S., Russell J.Q., Tschopp J., Budd R.C. Cellular FLIP (long form) regulates CD8(+) T cell activation through caspase-8-dependent NF-kappa B activation. J. Immunol. 2005, 174:5270-5278.
42. Kataoka T., Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-kappaB signaling pathway. Mol. Cell. Biol. 2004, 24:2627-2636.
43. Wachter T., Sprick M., Hausmann D., Kerstan A., McPherson K., Stassi G., Brocker E.B., Walczak H., Leverkus M. cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes. J. Biol. Chem. 2004, 279:52824-52834.
44. Kavuri S.M., Geserick P., Berg D., Dimitrova D.P., Feoktistova M., Siegmund D., Gollnick H., Neumann M., Wajant H., Leverkus M. Cellular FLICE-inhibitory protein (cFLIP) isoforms block CD95- and TRAIL death receptor-induced gene induction irrespective of processing of caspase-8 or cFLIP in the death-inducing signaling complex. J. Biol. Chem. 2011, 286:16631-16646.
45. Song J.H., Tse M.C., Bellail A., Phuphanich S., Khuri F., Kneteman N.M., Hao C. Lipid rafts and nonrafts mediate tumor necrosis factor related apoptosis-inducing ligand induced apoptotic and nonapoptotic signals in non small cell lung carcinoma cells. Cancer Res. 2007, 67:6946-6955.
46. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G. Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat. Rev. Mol. Cell Biol. 2010, 11:700-714.
47. Oberst A., Dillon C.P., Weinlich R., McCormick L.L., Fitzgerald P., Pop C., Hakem R., Salvesen G.S., Green D.R. Catalytic activity of the caspase-8-FLIP(L) complex inhibits RIPK3-dependent necrosis. Nature 2011, 471:363-367.
48. Vanlangenakker N., Bertrand M.J., Bogaert P., Vandenabeele P., Berghe T.V. TNF-induced necroptosis in L929 cells is tightly regulated by multiple TNFR1 complex I and II members. Cell Death Dis. 2011, 2:e230.
49. Tenev T., Bianchi K., Darding M., Broemer M., Langlais C., Wallberg F., Zachariou A., Lopez J., MacFarlane M., Cain K., Meier P. The Ripoptosome, a signaling platform that assembles in response to genotoxic stress and loss of IAPs. Mol. Cell 2011, 43:432-448.
50. Feoktistova M., Geserick P., Kellert B., Dimitrova D.P., Langlais C., Hupe M., Cain K., MacFarlane M., Hacker G., Leverkus M. cIAPs block Ripoptosome formation, a RIP1/caspase-8 containing intracellular cell death complex differentially regulated by cFLIP isoforms. Mol. Cell 2011, 43:449-463.
51. Schmitz I., Krueger A., Baumann S., Schulze-Bergkamen H., Krammer P.H., Kirchhoff S. An IL-2-dependent switch between CD95 signaling pathways sensitizes primary human T cells toward CD95-mediated activation-induced cell death. J. Immunol. 2003, 171:2930-2936.
52. Kirchhoff S., Muller W.W., Krueger A., Schmitz I., Krammer P.H. TCR-mediated up-regulation of c-FLIPshort correlates with resistance toward CD95-mediated apoptosis by blocking death-inducing signaling complex activity. J. Immunol. 2000, 165:6293-6300.
53. Gordy C., Pua H., Sempowski G.D., He Y.W. Regulation of steady-state neutrophil homeostasis by macrophages. Blood 2011, 117:618-629.
54. Pearson G., Robinson F., Beers Gibson T., Xu B.E., Karandikar M., Berman K., Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 2001, 22:153-183.
55. Nakajima A., Komazawa-Sakon S., Takekawa M., Sasazuki T., Yeh W.C., Yagita H., Okumura K., Nakano H. An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 2006, 25:5549-5559.
56. Kober A.M., Legewie S., Pforr C., Fricker N., Eils R., Krammer P.H., Lavrik I.N. Caspase-8 activity has an essential role in CD95/Fas-mediated MAPK activation. Cell Death Dis. 2011, 2:e212.
57. Safa A.R., Day T.W., Wu C.H. Cellular FLICE-like inhibitory protein (C-FLIP): a novel target for cancer therapy. Curr. Cancer Drug Targets 2008, 8:37-46.